BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 6488175)

  • 1. Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia.
    Hilton J
    Cancer Res; 1984 Nov; 44(11):5156-60. PubMed ID: 6488175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines.
    Sladek NE; Landkamer GJ
    Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
    Kohn FR; Landkamer GJ; Manthey CL; Ramsay NK; Sladek NE
    Cancer Res; 1987 Jun; 47(12):3180-5. PubMed ID: 3034402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of aldehyde dehydrogenase isozymes in cellular resistance to the alkylating agent cyclophosphamide.
    Russo JE; Hilton J; Colvin OM
    Prog Clin Biol Res; 1989; 290():65-79. PubMed ID: 2726824
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
    Maki PA; Sladek NE
    Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells.
    Russo JE; Hilton J
    Cancer Res; 1988 Jun; 48(11):2963-8. PubMed ID: 3365687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard.
    Surya YA; Rosenfeld JM; Hillcoat BL
    Cancer Treat Rep; 1978 Jan; 62(1):23-9. PubMed ID: 564237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
    Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
    Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells.
    Hilton J
    Biochem Pharmacol; 1984 Jun; 33(12):1867-72. PubMed ID: 6732847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde dehydrogenase-catalyzed bioinactivation of cyclophosphamide.
    Manthey CL; Sladek NE
    Prog Clin Biol Res; 1989; 290():49-63. PubMed ID: 2726823
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance.
    Sreerama L; Sladek NE
    Cancer Res; 1994 Apr; 54(8):2176-85. PubMed ID: 8174125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of DNA damage in the resistance of human chronic myeloid leukemia cells to cyclophosphamide analogues.
    Andersson BS; Mroue M; Britten RA; Murray D
    Cancer Res; 1994 Oct; 54(20):5394-400. PubMed ID: 7923171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expressions of glucose-6-phosphate dehydrogenase and cytosolic aldehyde dehydrogenase and elevation of reduced glutathione level in cyclophosphamide-resistant human leukemia cells.
    Tsukamoto N; Chen J; Yoshida A
    Blood Cells Mol Dis; 1998 Jun; 24(2):231-8. PubMed ID: 9714700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of aldehyde dehydrogenase (ALDH) in the detoxication of cyclophosphamide (CP) in rat embryos.
    Mirkes PE; Ellison A; Little SA
    Adv Exp Med Biol; 1991; 284():85-95. PubMed ID: 2053494
    [No Abstract]   [Full Text] [Related]  

  • 15. Resistance of rat embryonic heart cells to the cytotoxic effects of cyclophosphamide does not involve aldehyde dehydrogenase-mediated metabolism.
    Mirkes PE; Ellison A; Little SA
    Teratology; 1991 Apr; 43(4):307-18. PubMed ID: 2048039
    [No Abstract]   [Full Text] [Related]  

  • 16. Collateral sensitivity to cross-linking agents exhibited by cultured L1210 cells resistant to oxazaphosphorines.
    Sladek NE; Low JE; Landkamer GJ
    Cancer Res; 1985 Feb; 45(2):625-9. PubMed ID: 3967238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antitumor activity of 4-amino 4-methyl 2-pentyne 1-al, an inhibitor of aldehyde dehydrogenase.
    Quemener V; Quash G; Moulinoux JP; Penlap V; Ripoll H; Havouis R; Doutheau A; Goré J
    In Vivo; 1989; 3(5):325-30. PubMed ID: 2519873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Half-life of oxazaphosphorines in biological fluids.
    Sladek NE; Powers JF; Grage GM
    Drug Metab Dispos; 1984; 12(5):553-9. PubMed ID: 6149904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM; Wodinsky I; Myles A
    Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and expression of the cytosolic aldehyde dehydrogenase gene in cyclophosphamide-resistant murine leukemia L1210 cells.
    Radin AI; Zhoa XL; Woo TH; Colvin OM; Hilton J
    Biochem Pharmacol; 1991 Oct; 42(10):1933-9. PubMed ID: 1741771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.